#153233

Anti-CD44 [BU93]

Cat. #153233

Anti-CD44 [BU93]

Cat. #: 153233

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: CD44

Class: Monoclonal

Application: IHC

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Margaret Goodall

Institute: University of Birmingham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CD44 [BU93]
  • Alternate name: Cell differentiation 44; Homing cell adhesion molecule; HCAM; phagocytic glycoprotein-1; Pgp-1; Hermes antigen; lymphocyte homing receptor; ECM-III; HUTCH-1.
  • Clone: BU93
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC
  • Description: The CD44 antigen is a cell-surface glycoprotein involved in cell to cell and cell-matrix interactions, cell adhesion and migration, which it achieves through its affinity for hyaluronic acid (HA) and possibly also through its affinity for other ligands such as osteopontin, collagens, and matrix metalloproteinases. CD44 is also involved in lymphocyte activation, recirculation and homing, and in hematopoiesis. Altered expression or dysfunction causes numerous pathogenic phenotypes.
  • Isotype: IgG1

Target Details

  • Target: CD44
  • Target background: The CD44 antigen is a cell-surface glycoprotein involved in cell to cell and cell-matrix interactions, cell adhesion and migration, which it achieves through its affinity for hyaluronic acid (HA) and possibly also through its affinity for other ligands such as osteopontin, collagens, and matrix metalloproteinases. CD44 is also involved in lymphocyte activation, recirculation and homing, and in hematopoiesis. Altered expression or dysfunction causes numerous pathogenic phenotypes.

Applications

  • Application: IHC

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Leucocyte Typing IV, (1989): edited by W. Knapp, OUP, Oxford.
  • Leucocyte Typing V, (1995): edited by S.F. Schlossman, OUP, Oxford.
  • Leucocyte Typing VII, (2002): edited by D.Y. Mason, OUP, Oxford.